National Health Investors (MEX:NHI) EBITDA Margin %: 67.43% (As of Mar. 2026) — 22% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NHI National Health Investors Inc MEX:NHI
83 GF Score
Price MXN1,484.43
GF Value MXN1,502.86
! 4 Warning Signs
View Full Analysis

What is National Health Investors EBITDA Margin %?

National Health Investors MEX:NHI 83 EBITDA Margin % is 67.43% as of Mar. 2026, which is 22% below its 10-year median of 86.34. GuruFocus rates MEX:NHI with a GF Score™ of 83/100 and a GF Value™ of MXN1,502.86. The stock has 4 warning signs investors should review. Among 742 REITs companies, National Health Investors ranks better than 53.1% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. National Health Investors's EBITDA for the three months ended in Mar. 2026 was MXN1,400 Mil. National Health Investors's Revenue for the three months ended in Mar. 2026 was MXN2,076 Mil. Therefore, National Health Investors's EBITDA margin for the quarter that ended in Mar. 2026 was 67.43%.


National Health Investors  (MEX:NHI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


National Health Investors EBITDA Margin % Related Terms


National Health Investors EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for National Health Investors's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

National Health Investors EBITDA Margin % Chart

National Health Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.66 64.25 81.25 78.82 73.39

National Health Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.28 77.95 73.24 68.86 67.43

MEX:NHI vs MPT, SBRA, DHC: EBITDA Margin % Comparison

For the REIT - Healthcare Facilities subindustry, National Health Investors's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Health Investors EBITDA Margin % vs REITs Industry

For the REITs industry and Real Estate sector, National Health Investors's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where National Health Investors's EBITDA Margin % falls into.


MEX:NHI
83GF Score
National Health Investors Inc MEX:NHI
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

National Health Investors EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

National Health Investors's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=4963.667/6763.445
=73.39 %

National Health Investors's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=1399.86/2076.105
=67.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 67.43% mean?
National Health Investors (MEX:NHI) has a EBITDA Margin % of 67.43% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on National Health Investors and its competitors. This is 22% below median its historical median of 86.34. Over the past decade, National Health Investors' EBITDA Margin % has ranged from 64.25 to 103.09. According to the industry distribution chart, National Health Investors ranks #348 out of 742 companies in the REITs industry, placing it in the top 46.9%.
Is National Health Investors' EBITDA Margin % too high?
National Health Investors' current EBITDA Margin % of 67.43% is 22% below median its 10-year median of 86.34. Over the past 10 years, this metric has ranged from a low of 64.25 to a high of 103.09. The REITs industry median EBITDA Margin % is 69.48. National Health Investors' value of 67.43% is 3% below this industry median. Based on the distribution chart, National Health Investors ranks #348 out of 742 companies in the REITs industry, which is above the industry midpoint. Overall, National Health Investors has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does National Health Investors' EBITDA Margin % compare to MPT and SBRA?
According to the REITs industry distribution chart, National Health Investors ranks #348 out of 742 companies for EBITDA Margin %. This puts National Health Investors in the upper half of its industry. The industry median EBITDA Margin % is 69.48. National Health Investors' value of 67.43% is 3% below this benchmark. Historically, National Health Investors' own EBITDA Margin % has ranged from 64.25 to 103.09 over the past decade. While the company's 10-year median is 86.34 vs. the industry median of 69.48, National Health Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a REITs company?
The median EBITDA Margin % among REITs companies is 69.48, based on 742 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Health Investors's current EBITDA Margin % of 67.43% is 3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on National Health Investors and its competitors. For the REITs industry, the median EBITDA Margin % is 69.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Health Investors's current EBITDA Margin % is 67.43%, which is 22% below median its own 10-year median of 86.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Health Investors stock overvalued right now?
National Health Investors (MEX:NHI) has a current EBITDA Margin % of 67.43%. The stock's GF Value™ is MXN1,502.86, compared to a current price of MXN1,484.43 — trading 1.2% below its estimated fair value. The current EBITDA Margin % is 67.43%, which is 22% below median its 10-year median of 86.34 and 3% below the REITs industry median of 69.48. National Health Investors' overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For National Health Investors (MEX:NHI), the current EBITDA Margin % is 67.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is National Health Investors (MEX:NHI) Overvalued in 2026?

Based on GuruFocus' analysis, National Health Investors stock appears to be undervalued. The current stock price of MXN1,484.43 is trading 1.2% below its estimated GF Value™ of MXN1,502.86.

Key valuation signals for MEX:NHI:

  • EBITDA Margin %: 67.43% (22% below median its 10-year median of 86.34)
  • GF Value™: MXN1,502.86 vs. price of MXN1,484.43 (1.2% below fair value)
  • GF Score™: 83/100 with 4 warning signs
  • Industry Position: 3% below the REITs median (#348 of 742)

No single metric tells the full story. See the MEX:NHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


National Health Investors Business Description

Industry Real EstateREITs
Other Exchanges NHI:USAWX6:Germany
Address 222 Robert Rose Drive, Murfreesboro, TN, USA, 37129
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
83GF Score

Get the complete analysis for MEX:NHI

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,484.43
Price
MXN1,502.86
GF Value